Back
DHR logo

Danaher Corp (DHR)

Life Sciences Tools & Services
DHR · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →
$219.80
+1.15%

Weekly undervalued picks

Price · 1 year
Loading live analysis…
Loading analysis…

Intrinsic Investor is for research and education only. Not financial advice.

Key metrics

EPS
$5.05
ROE
7.1%
Gross margin
59.0%
Debt/Equity
0.37x
Revenue growth
3.7%

Danaher Corp — company intelligence

Earnings surprises

Q2 2026$1.94 vs $1.85 est+4.7%
Q1 2026$2.06 vs $1.96 est+5.3%
Q4 2025$2.23 vs $2.17 est+2.6%
Q3 2025$1.89 vs $1.74 est+8.7%

Analyst consensus · 32 analysts

27 Buy5 Hold0 Sell
Updated Oct 4, 2026

Insider activity · 90 days

18 buys6 sellsnet +3,514,027 shares
Blair RainerSell 7,755 · Aug 21, 2026
Blair RainerSell 11,307 · Aug 21, 2026
Blair RainerSell 39,193 · Aug 21, 2026

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Weekly undervalued picks

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.